San Jose, CA, United States of America

Li Zhou

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Immune-Onc Therapeutics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Li Zhou. Retrieved from https://idiyas.com/inventor/li-zhou-b78mj4a5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Li Zhou

Introduction

Li Zhou is a prominent inventor based in San Jose, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic solutions. His work is characterized by a commitment to advancing medical science and improving patient outcomes.

Latest Patents

Li Zhou holds a patent for "Novel Anti-LILRB4 Antibodies and Derivative Products." This innovative patent represents a breakthrough in the treatment of various diseases, showcasing his expertise and dedication to research and development. He has 1 patent to his name, reflecting his impactful contributions to the field.

Career Highlights

Li Zhou is currently employed at Immune-Onc Therapeutics, Inc., where he continues to push the boundaries of scientific research. His role at the company allows him to collaborate with other talented professionals and contribute to groundbreaking projects in immunotherapy.

Collaborations

Throughout his career, Li Zhou has worked alongside notable colleagues, including J Paul Woodard and Ji Li. These collaborations have fostered a dynamic environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Li Zhou's work exemplifies the spirit of innovation in biotechnology. His contributions, particularly in the development of novel antibodies, highlight the importance of research in improving healthcare solutions. His ongoing efforts at Immune-Onc Therapeutics, Inc. continue to inspire future advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…